[ad_1] After an everything rally that pushed major stock indexes near new highs, some investors just want the good stuff. They are looking for quality stocks, broadly defined as shares…
Tag: Johnson & Johnson
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but…
Johnson & Johnson to Acquire Cancer-Treatment Developer Ambrx for $2 Billion
[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
[ad_1] An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson…
Investors Hope the Dogs of the Dow Can Find Their Bite
[ad_1] The Dogs of the Dow weren’t the best in show last year, but the recent rally in beaten-down corners of the stock market is giving hope to fans of…
Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B
[ad_1] Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal. The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx…